These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7870735

  • 1. [Blood proteolytic systems in patients with pulmonary tuberculosis].
    Khudzik LB, Morozova TI.
    Probl Tuberk; 1994; (5):56-8. PubMed ID: 7870735
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of proteolytic and antiproteolytic blood system on hemocoagulation in phthisiosurgical patients].
    Bogush LK, Kaminskaia GO, Serebrianaia BA, Shipeneva NM.
    Grudn Khir; 1977; (1):39-43. PubMed ID: 838384
    [No Abstract] [Full Text] [Related]

  • 3. [Regulation of the activity of the blood kinin system as a method for the pathogenetic therapy of pulmonary tuberculosis].
    Priĭmak AA, Makinskiĭ AI.
    Vrach Delo; 1985 Oct; (10):95-7. PubMed ID: 3841435
    [No Abstract] [Full Text] [Related]

  • 4. [Proteolytic processes in the bronchial contents in pulmonary tuberculosis].
    Zaks OV, Pisarevskaia LI.
    Vrach Delo; 1988 Oct; (10):41-2. PubMed ID: 3064419
    [No Abstract] [Full Text] [Related]

  • 5. [Indications for using antikinin preparations and blood kinin system activators in the combined treatment of pulmonary tuberculosis].
    Makinskiĭ AI.
    Probl Tuberk; 1981 Oct; (10):33-7. PubMed ID: 7312848
    [No Abstract] [Full Text] [Related]

  • 6. [Activity of proteolytic enzymes and their inhibitors in the sputum of patients with pulmonary tuberculosis].
    Kaminskaia GO, Zaks OV.
    Probl Tuberk; 1987 Oct; (2):48-54. PubMed ID: 3554214
    [No Abstract] [Full Text] [Related]

  • 7. [Activity of proteolytic enzymes and their inhibitors in the pulmonary tissue of guinea pigs developing experimental tuberculosis].
    Zhukova NL, Gedymin LE.
    Probl Tuberk; 1986 Oct; (9):54-8. PubMed ID: 2431409
    [No Abstract] [Full Text] [Related]

  • 8. [Use of decaris in the complex treatment of destructive pulmonary tuberculosis].
    German AK, Logiĭko VL.
    Vrach Delo; 1981 Aug; (8):81-3. PubMed ID: 7269517
    [No Abstract] [Full Text] [Related]

  • 9. [Impact of ozonized sorbent hemocarboperfusion on kallikrein-kinin system in patients with progressive pulmonary tuberculosis].
    Belianin II, Kaminskaia GO.
    Probl Tuberk; 1999 Aug; (1):59-61. PubMed ID: 10199189
    [Abstract] [Full Text] [Related]

  • 10. [Effects of natural protease inhibitors on hemostasis and serum proteolysis blockers in patients with pulmonary tuberculosis].
    Morozova TI, Khudzik LB.
    Probl Tuberk; 1993 Aug; (3):27-30. PubMed ID: 7527148
    [Abstract] [Full Text] [Related]

  • 11. [Use of the antikinin preparation prodectin in the complex treatment of pulmonary tuberculosis patients].
    Keleberda KIa, Svistunova AS, Kaminskaia GO, Kordonskaia VM.
    Probl Tuberk; 1982 Oct; (10):42-5. PubMed ID: 7178102
    [No Abstract] [Full Text] [Related]

  • 12. [Blood coagulation in patients with pulmonary tuberculosis in the course of treatment with tuberculostatic agents of the 1st and 2nd series].
    Chaban VM.
    Vrach Delo; 1971 Nov; 11():75-8. PubMed ID: 5143286
    [No Abstract] [Full Text] [Related]

  • 13. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].
    Medus AI, Pisarevskaia LI, Nikishina EV.
    Voen Med Zh; 1999 Oct; 320(10):65-7, 96. PubMed ID: 10605346
    [Abstract] [Full Text] [Related]

  • 14. [Effect of intravenous administration of 1st series preparations on blood coagulation in pulmonary and renal tuberculosis].
    Radkevich RA, Utkin VV, Gushanskiĭ AM.
    Probl Tuberk; 1970 Oct; 48(7):31-5. PubMed ID: 5486078
    [No Abstract] [Full Text] [Related]

  • 15. [Morphological changes of internal organs during treatment of tuberculosis with proteolytic enzymes].
    Shlapak PT, Shvartsman LI.
    Probl Tuberk; 1972 Oct; 50(4):79-83. PubMed ID: 5019370
    [No Abstract] [Full Text] [Related]

  • 16. [Proteolytic enzymes and their biological function].
    Solov'eva NI, Eliseeva IuA, Lokshina LA.
    Vestn Ross Akad Med Nauk; 1995 Oct; (2):3-9. PubMed ID: 7756928
    [Abstract] [Full Text] [Related]

  • 17. [Blood coagulation and anticoagulation system indices following administration of heparin and antitubercular agents in patients with pulmonary tuberculosis].
    Gaĭbarov KK.
    Probl Tuberk; 1972 Oct; 50(1):88-9. PubMed ID: 5010790
    [No Abstract] [Full Text] [Related]

  • 18. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
    Averchenkov VM, Lomachenkov VD, Fedotova NI, Meshkova RIa.
    Probl Tuberk; 1998 Oct; (2):20-2. PubMed ID: 9613178
    [Abstract] [Full Text] [Related]

  • 19. [Use of antikinin preparations as pathogenetic agents in the overall therapy of tuberculosis].
    Makinskiĭ AI.
    Probl Tuberk; 1978 Apr; (4):70-4. PubMed ID: 349551
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.